Amlodipine Besylate prices in May xxxx saw a sharp fall in Germany, reversing the rising price tendency for April. The sharp fall was dominated primarily by muted domestic pharma demand for Amlodipine Besylate amid ongoing inflationary pressure and all-pervasive availability of stocks.
Realignments in international trade and regional logistical disruption also contributed to a negative market environment that positively fueled suppliers to adopt bold price actions to defend throughput. Amlodipine Besylate prices eventually settled at USD xxxxx/MT CFR Hamburg.
Despite some restocking efforts during the first week of May, these actions were insufficient to create sustaining momentum for pharmaceutical sales. Market players in Germany were confronted with the consequences of overstocking, in addition to cargoes originally destined for the United States that were redirected to European ports. This unexpected lift was prompted by the temporary U.S. tariffs on Chinese...
